Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Gilead Sciences
GILD
|
$238M |
| 2 |
Johnson & Johnson
JNJ
|
$224M |
| 3 |
MON
Monsanto Co
MON
|
$219M |
| 4 |
AET
Aetna Inc
AET
|
$215M |
| 5 |
Broadcom
AVGO
|
$179M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$242M |
| 2 |
Microsoft
MSFT
|
$232M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$205M |
| 4 |
Home Depot
HD
|
$188M |
| 5 |
Nike
NKE
|
$187M |
Sector Composition
| 1 | Financials | 14.12% |
| 2 | Technology | 13.1% |
| 3 | Healthcare | 12.08% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Target
TGT
$41.7B
| $129M | 0.2% |
+1,789,800
| New | +$129M |
|
77
Ball Corp
BALL
$13.6B
| $127M | 0.2% |
1,688,711
+382,800
| +29% | +$28.7M |
|
78
Intuitive Surgical
ISRG
$167B
| $127M | 0.2% |
199,891
+117,621
| +143% | +$74.6M |
|
79
Align Technology
ALGN
$9.86B
| $127M | 0.2% |
1,316,500
+372,300
| +39% | +$35.8M |
|
80
DuPont de Nemours
DD
$31.7B
| $126M | 0.2% |
2,209,500
+1,185,300
| +116% | +$67.8M |
|
|
FNSR
81
DELISTED
Finisar Corp
FNSR
| $126M | 0.2% |
4,160,600
+843,090
| +25% | +$25.5M |
|
82
RTX Corp
RTX
$210B
| $125M | 0.2% |
1,136,400
+578,500
| +104% | +$63.4M |
|
83
AutoZone
AZO
$69.7B
| $124M | 0.2% |
157,600
+59,200
| +60% | +$46.8M |
|
84
Herbalife
HLF
$1.02B
| $124M | 0.2% |
2,579,200
-299,700
| -10% | -$14.4M |
|
85
Welltower
WELL
$112B
| $123M | 0.19% |
1,837,200
-224,300
| -11% | -$15M |
|
86
Kinross Gold
KGC
$26.5B
| $121M | 0.19% |
38,818,472
+4,814,773
| +14% | +$15M |
|
87
Markel Group
MKL
$24.6B
| $120M | 0.19% |
132,300
+14,000
| +12% | +$12.7M |
|
88
UDR
UDR
$12.7B
| $120M | 0.19% |
3,277,800
+781,700
| +31% | +$28.5M |
|
89
GSK
GSK
$79.1B
| $119M | 0.19% |
3,085,500
+2,155,500
| +232% | +$83M |
|
90
Danaher
DHR
$145B
| $118M | 0.19% |
1,522,100
+665,100
| +78% | +$51.8M |
|
|
ATVI
91
DELISTED
Activision Blizzard Inc.
ATVI
| $117M | 0.19% |
+3,248,598
| New | +$117M |
|
|
BRCD
92
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $117M | 0.18% |
9,343,049
+2,014,724
| +27% | +$25.2M |
|
93
Clorox
CLX
$15B
| $116M | 0.18% |
964,000
-75,600
| -7% | -$9.07M |
|
94
Thermo Fisher Scientific
TMO
$183B
| $115M | 0.18% |
+813,644
| New | +$115M |
|
95
Abbott
ABT
$227B
| $114M | 0.18% |
2,980,400
+2,323,100
| +353% | +$89.2M |
|
|
BCR
96
DELISTED
CR Bard Inc.
BCR
| $114M | 0.18% |
509,400
-287,800
| -36% | -$64.7M |
|
97
TFS Financial
TFSL
$3.85B
| $114M | 0.18% |
5,982,022
+312,700
| +6% | +$5.95M |
|
98
Toyota
TM
$252B
| $114M | 0.18% |
971,800
-17,600
| -2% | -$2.06M |
|
99
Starbucks
SBUX
$99.5B
| $114M | 0.18% |
+2,050,084
| New | +$114M |
|
100
Eli Lilly
LLY
$659B
| $113M | 0.18% |
1,539,200
+617,000
| +67% | +$45.4M |
|